BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26684511)

  • 1. Native Myocardial T1 as a Biomarker of Cardiac Structure in Non-Ischemic Cardiomyopathy.
    Shah RV; Kato S; Roujol S; Murthy V; Bellm S; Kashem A; Basha T; Jang J; Eisman AS; Manning WJ; Nezafat R
    Am J Cardiol; 2016 Jan; 117(2):282-8. PubMed ID: 26684511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular volume fraction is more closely associated with altered regional left ventricular velocities than left ventricular ejection fraction in nonischemic cardiomyopathy.
    Collins J; Sommerville C; Magrath P; Spottiswoode B; Freed BH; Benzuly KH; Gordon R; Vidula H; Lee DC; Yancy C; Carr J; Markl M
    Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25552491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping.
    Ntusi NAB; Piechnik SK; Francis JM; Ferreira VM; Matthews PM; Robson MD; Wordsworth PB; Neubauer S; Karamitsos TD
    JACC Cardiovasc Imaging; 2015 May; 8(5):526-536. PubMed ID: 25890584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging.
    Florian A; Ludwig A; Rösch S; Yildiz H; Sechtem U; Yilmaz A
    Eur Heart J Cardiovasc Imaging; 2014 Sep; 15(9):1004-12. PubMed ID: 24686257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular volume fraction assessed using cardiovascular magnetic resonance can predict improvement in left ventricular ejection fraction in patients with dilated cardiomyopathy.
    Inui K; Asai K; Tachi M; Yoshinaga A; Izumi Y; Kubota Y; Murai K; Tsukada YT; Amano Y; Kumita S; Shimizu W
    Heart Vessels; 2018 Oct; 33(10):1195-1203. PubMed ID: 29560528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased left ventricular extracellular volume and enhanced twist function in type 1 diabetic individuals.
    Vasanji Z; Sigal RJ; Eves ND; Isaac DL; Friedrich MG; Chow K; Thompson RB
    J Appl Physiol (1985); 2017 Aug; 123(2):394-401. PubMed ID: 28522755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial T1 mapping and extracellular volume quantification in patients with left ventricular non-compaction cardiomyopathy.
    Araujo-Filho JAB; Assuncao AN; Tavares de Melo MD; Bière L; Lima CR; Dantas RN; Nomura CH; Salemi VMC; Jerosch-Herold M; Parga JR
    Eur Heart J Cardiovasc Imaging; 2018 Aug; 19(8):888-895. PubMed ID: 29518212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive cardiac magnetic resonance T1, T2, and extracellular volume mapping to define Duchenne cardiomyopathy.
    Sunthankar SD; George-Durrett K; Crum K; Slaughter JC; Kasten J; Raucci FJ; Markham LW; Soslow JH
    J Cardiovasc Magn Reson; 2023 Jul; 25(1):44. PubMed ID: 37517994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased myocardial native T1 and extracellular volume in patients with Duchenne muscular dystrophy.
    Soslow JH; Damon SM; Crum K; Lawson MA; Slaughter JC; Xu M; Arai AE; Sawyer DB; Parra DA; Damon BM; Markham LW
    J Cardiovasc Magn Reson; 2016 Jan; 18():5. PubMed ID: 26795569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evaluation of non-ischemic dilated cardiomyopathy with T1 mapping and ECV methods using 3T cardiac MRI.
    Görmeli CA; Özdemir ZM; Kahraman AS; Yağmur J; Özdemir R; Çolak C
    Radiol Med; 2017 Feb; 122(2):106-112. PubMed ID: 27785679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T1 and T2 mapping for early diagnosis of dilated non-ischaemic cardiomyopathy in middle-aged patients and differentiation from normal physiological adaptation.
    Mordi I; Carrick D; Bezerra H; Tzemos N
    Eur Heart J Cardiovasc Imaging; 2016 Jul; 17(7):797-803. PubMed ID: 26358692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Native T1 Mapping and Extracellular Volume Mapping for the Assessment of Diffuse Myocardial Fibrosis in Dilated Cardiomyopathy.
    Nakamori S; Dohi K; Ishida M; Goto Y; Imanaka-Yoshida K; Omori T; Goto I; Kumagai N; Fujimoto N; Ichikawa Y; Kitagawa K; Yamada N; Sakuma H; Ito M
    JACC Cardiovasc Imaging; 2018 Jan; 11(1):48-59. PubMed ID: 28624408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anthracycline-Associated T1 Mapping Characteristics Are Elevated Independent of the Presence of Cardiovascular Comorbidities in Cancer Survivors.
    Jordan JH; Vasu S; Morgan TM; D'Agostino RB; Meléndez GC; Hamilton CA; Arai AE; Liu S; Liu CY; Lima JA; Bluemke DA; Burke GL; Hundley WG
    Circ Cardiovasc Imaging; 2016 Aug; 9(8):. PubMed ID: 27502058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular Volume Fraction for Characterization of Patients With Heart Failure and Preserved Ejection Fraction.
    Rommel KP; von Roeder M; Latuscynski K; Oberueck C; Blazek S; Fengler K; Besler C; Sandri M; Lücke C; Gutberlet M; Linke A; Schuler G; Lurz P
    J Am Coll Cardiol; 2016 Apr; 67(15):1815-1825. PubMed ID: 27081022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of myocardial extracellular volume fraction in nonischaemic dilated cardiomyopathy.
    Barison A; Del Torto A; Chiappino S; Aquaro GD; Todiere G; Vergaro G; Passino C; Lombardi M; Emdin M; Masci PG
    J Cardiovasc Med (Hagerstown); 2015 Oct; 16(10):681-7. PubMed ID: 26090916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac magnetic resonance including parametric mapping in acute Takotsubo syndrome: Preliminary findings.
    Dabir D; Luetkens J; Kuetting DLR; Feisst A; Isaak A; Schild HH; Thomas D
    Eur J Radiol; 2019 Apr; 113():217-224. PubMed ID: 30927950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial tissue characterization and strain analysis in healthy pregnant women using cardiovascular magnetic resonance native T1 mapping and feature tracking technique.
    Nii M; Ishida M; Dohi K; Tanaka H; Kondo E; Ito M; Sakuma H; Ikeda T
    J Cardiovasc Magn Reson; 2018 Aug; 20(1):52. PubMed ID: 30068369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of myocardial iron deficiency in nonischemic heart failure by cardiac T2* magnetic resonance imaging.
    Nagao M; Matsuo Y; Kamitani T; Yonezawa M; Yamasaki Y; Kawanami S; Abe K; Mukai Y; Higo T; Yabuuchi H; Takemura A; Yoshiura T; Sunagawa K; Honda H
    Am J Cardiol; 2014 Mar; 113(6):1024-30. PubMed ID: 24461766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffuse ventricular fibrosis in atrial fibrillation: noninvasive evaluation and relationships with aging and systolic dysfunction.
    Ling LH; Kistler PM; Ellims AH; Iles LM; Lee G; Hughes GL; Kalman JM; Kaye DM; Taylor AJ
    J Am Coll Cardiol; 2012 Dec; 60(23):2402-8. PubMed ID: 23141493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CMR imaging biosignature of cardiac involvement due to cancer-related treatment by T1 and T2 mapping.
    Haslbauer JD; Lindner S; Valbuena-Lopez S; Zainal H; Zhou H; D'Angelo T; Pathan F; Arendt CA; Bug G; Serve H; Vogl TJ; Zeiher AM; Carr-White G; Nagel E; Puntmann VO
    Int J Cardiol; 2019 Jan; 275():179-186. PubMed ID: 30360992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.